Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT05710120
Eligibility Criteria:
Inclusion Criteria:
* 18+ years of age
* In care at an AIDS Healthcare Foundation Healthcare Center
* HCV screening eligible
Individuals who are HCV screening eligible include:
* HCV unknown: Never received an HCV antibody, RNA, or genotype test
* Previously HCV negative, high-risk for HCV infection: HIV-infected men who have sex with men or people who inject drugs with ≥ 1 prior negative HCV antibody or RNA test(s) who have not been screened in the prior 12 months
Exclusion Criteria:
* \<18 years of age
* Diagnosed HCV infection (i.e., reactive HCV antibody, detectable HCV RNA test, or HCV genotype test)
Individuals with diagnosed HCV infection include:
* Acute HCV infection, untreated or in treatment
* Chronic HCV infection, untreated or in treatment
* Spontaneous clearance of prior HCV infection
* Sustained virologic response after direct acting antiviral therapy for prior HCV infection
* Treatment failure after direct acting antiviral therapy for prior HCV infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05710120
Study Brief:
Protocol Section:
NCT05710120